Nur Neyal, MD

Posdoctoral Research Fellow in Radiology & Neurology @MayoClinic | Alum @KocUniversity ‘21

[Burcu Zeydan @burcuzeydanmd]

📣👩🏻‍💻Great discussions at the #CMSAN Annual Symposium 2025 @MayoClinic - multidisciplinary research on MS and autoimmune disorders from a fantastic lineup of speakers. Happy to be part of it! A few moments from the symposium… @EoinFlanagan14 @chenmayo @Div_Dubey @albertaboseif

[Eoin Flanagan @EoinFlanagan14]

Such an honor to host the great Amit Bar-Or from @PennNeurology as visiting faculty at @MayoClinicNeuro to talk on the immunolobiology of #MS ➡️A wonderful person, outstanding researcher and superb mentor of trainees ➡️ A role model for all of us 👇

[Burcu Zeydan @burcuzeydanmd]

📣 This study provides a better understanding of the pathological mechanisms in the thalamus in MS using cellular/molecular advanced imaging modalities of MR spectroscopy and PET https://t.co/A1SJdyl2OO

[Burcu Zeydan @burcuzeydanmd]

📣Excited to share our new study on MR spectroscopy & PET in the thalamus in MS 📣Increased innate immune activity through the glial interplay of microglia and astrocytes ➡️ neurodegeneration & decreased cognitive function in MS. Thalamus on 🔥 https://t.co/A1SJdyl2OO

[IJMSC @IJMSCtweets]

"Inflammatory activity in [#MultipleSclerosis] often attenuates with aging & #androgen modifying therapies...are frequently used in older men. We aimed to investigate if number of disease activity events would increase in ≥55 years [men] with MS on AMT." https://t.co/5HoMHqkXmr

[Nabeela Nathoo, MD, PhD, FRCPC @neuronathoo]

Proud to be one of the co-authors of this series on gender affirming care and interventions in MS. Without trying to understand all types of people living with MS, we cannot claim to provide equitable care to all.

[MSJ @MSJ_Research]

...and commentary from @MarcelloMoccia_ @UninaIT: We really hope this case series can support our clinical decisions and ultimately improve quality of life and health outcomes of gender-diverse people with #MultipleSclerosis.
🔽
https://t.co/rlkPWmSv4Y

2/🧵

[MSJ @MSJ_Research]

For the International #LGBT Pride Day 🌈 have a look at the case series from @nurneyal @MayoClinic on gender-affirming interventions and prognosis in #MultipleSclerosis.
🔽
https://t.co/Q3RJAqXTW6

1/🧵

[Albert Aboseif @albertaboseif]

📣Review: 🚨Despite similar rates of #MS among Black and White individuals, RCTs report a 93% White majority➡️social >> genetic factors drive disparate MS outcomes ➡️socioeconomic disadvantage influences disability progression
#DEIresearch Read more👇:
https://t.co/rvR15bL95W

[MSJ @MSJ_Research]

Falls in people with #MultipleSclerosis are more frequent in patients who are older, have higher disability, slower walking, and worse balance.

Study using patient-reported outcomes and wearable gait metrics from @SamanthaBanksMD @MayoClinicNeuro ▶️ https://t.co/FiDEmD3Upr

[MSJ @MSJ_Research]

Pre-pubertal onset #MultipleSclerosis was associated with severe symptoms, greater lesion burden, higher 10-year disability, and increased relapse rates when transitioning to peri- or post-puberty.

Study from @melindamagyari @Rigshospitalet @univca ▶️ https://t.co/gUO02qpqu4

[Burcu Zeydan @burcuzeydanmd]

📣Check out our study on a novel EMOJI-based patient-reported outcome measure 😁😒😴 in MS and other neurological disorders as a potential digital tool, which is fast and accessible 👩🏻‍💻
https://t.co/vqIoDJ6KM1 @EoinFlanagan14

[Burcu Zeydan @burcuzeydanmd]

📣📣Thalamus on FIRE🔥Thalamic microglia density on ER176 PET is highest in progressive MS followed by relapsing MS & controls. ER176 PET stands out as a promising molecular imaging biomarker of progression in MS https://t.co/DA82QZjbFH @nurneyal @LauraAiras1

[Burcu Zeydan @burcuzeydanmd]

Our new study👩🏻‍💻Men with MS >65 with prostate disease on androgen modifying therapies (AMT) may experience unexpected disease activity: AMT is not contraindicated in older men with MS but close monitoring is necessary https://t.co/kHzW1F4aT3 @JNI_Journal

[Ashley Winter MD || Urologist @AshleyGWinter]

Look up subacute sclerosing panencephalitis, Leah.

[Neurology Journal @GreenJournal]

Montreal Cognitive Assessment vs the Mini-Mental State Examination as a Screening Tool for Patients With Genetic Frontotemporal Dementia
https://t.co/tu1lxn5FpS

#NeuroTwitter #Dementia

[MSJ @MSJ_Research]

Upper cervical spinal cord atrophy was more pronounced in people with #MultipleSclerosis being older, males or menopause females, suggesting associations between hormones and neurodegeneration.

Study from @burcuzeydanmd @MayoClinicNeuro @MayoClinic ▶️https://t.co/9WhYySohBx

[Burcu Zeydan @burcuzeydanmd]

Our paper is out📣 impact of age, sex & hormones on neurodegeneration in MS➡️smaller upper cervical cord area in men than women & in postmenopausal women than premenopausal women 👩🏻‍💻https://t.co/TrrowvWxH5 @MSJ_Research @nurneyal @neuronathoo @EoinFlanagan14

[Ahmed Y. Azzam, MD, MEng, DSc(h.c.), FRCP @AhmedYAzzam]

11.7 Tesla Brain MRI 🧠 !

First scans from the world's most powerful MRI scanner! 🔥

It costs around 75 million euros for the 11.7 Tesla MRI machine! 😮 😲

#brain #Neurology #mri #HealthAwareness #radiology

[Burcu Zeydan @burcuzeydanmd]

👩🏻‍⚕️How can AI help improve and transform women’s health? Lively discussions on 🩺 AI-guided screening for cardiomyopathies 🩺 potential of virtual reality as an adjunctive therapy for pain and many other symptoms… @WHMayoClinic @DemiladeMD @ea_enningaPhD @ArvinFArani @nurneyal